Noxilizer and Sterigenics said today they inked a global trade agreement which will position Sterigenics as the exclusive provider of Noxilizer’s nitrogen dioxide contract sterilization services and feasibility and research studies for pharma, biotech and med device firms.

Baltimore, Md.-based Noxilizer said it expects to have the 1st NO2 sterilization systems operational at Sterigenics facilities in the US by the end of the year with additional installations following.

“We are very excited about our partnership with Sterigenics, as together we can rapidly expand NO2 sterilization capability for our customers. Noxilizer’s customers will now have large-scale facilities to meet their needs for contract services, redundancy and increasing volumes. Sterigenics has set a high standard for matching the needs of its customers with the best available sterilization technologies. Noxilizer shares this commitment to excellence and we look forward to working with the Sterigenics International team as they continue to reshape the market,” Noxilizer prez & CEO Lawrence Bruder said in a prepared statement.

As part of the agreement, Broadview Heights, Ohio-based Sterigenics will also offer NO2 sterilization consulting services to its customers, the companies said.

“Sterigenics is committed to providing our customers with efficient, state-of-the-art sterilization services using the processes best suited to their specific products. We regularly monitor new technologies and are excited to be able to add NO2 processing to our suite of offerings,” Sterigenics prez Philip Macnabb said in a press release.

(See the best minds in medtech live at DeviceTalks West, Dec. 11–12 in Orange County, Calif.)